Does it impact survival?


Washington - Sentinel lymph node biopsy may not be standard of care today in the management of patients with early melanoma and clinically negative nodes, but neither should it be considered an experimental technique, said Gary S. Rogers, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.